Related Experiment Video
Updated: Jan 17, 2026

In vitro Assessment of Aortic Regurgitation Using Four-Dimensional Flow Magnetic Resonance Imaging
Published on: February 25, 2022
New Cardiovascular Damage Staging Classification for Chronic Significant Aortic Regurgitation
Alice Bergeron1, Pilar Lopez Santi2, Jérémy Bernard1
1Institut universitaire de cardiologie et de pneumologie de Québec-Université Laval, Québec Heart & Lung Institute-Laval University, Québec City, Québec, Canada.
Insights
A new cardiovascular damage staging classification improves risk stratification for chronic aortic regurgitation (AR). This method enhances prediction of mortality and hospitalization, especially for asymptomatic patients.
Area of Science:
- Cardiology
- Echocardiography
- Cardiovascular Imaging
Background:
- Current chronic aortic regurgitation (AR) management relies on limited risk stratification methods.
- Existing guidelines inadequately predict outcomes based on AR severity, symptoms, and left ventricular (LV) status.
- There is a need for improved prognostic tools in chronic AR patients.
Purpose of the Study:
- To evaluate a novel staging classification for cardiovascular damage in chronic AR.
- To assess the prognostic value of this new classification for risk stratification.
- To determine if the new staging system improves prediction of mortality and cardiovascular events.
Main Methods:
- A cohort of 619 patients with moderate or severe AR underwent echocardiography.
- Patients were classified into 5 stages (0-4) based on the extent of cardiovascular damage.
- Primary endpoint was all-cause mortality; secondary endpoint was a composite of mortality and cardiovascular hospitalization.
Main Results:
- Cardiovascular damage stage was independently associated with increased risk of all-cause mortality (HR 1.49 per stage increase) and composite events (HR 1.17).
- Stage 2 or higher significantly increased the risk of all-cause mortality (HR 3.02) and composite events (HR 1.88).
- The new classification demonstrated incremental prognostic value, with a significant net reclassification index (NRI = 0.40, P < 0.001).
Conclusions:
- The novel cardiovascular damage staging classification offers significant prognostic value in chronic AR.
- This staging system can enhance risk stratification and guide intervention decisions, particularly in asymptomatic patients.
- The classification provides a more comprehensive assessment of disease burden beyond traditional metrics.
Background:
Current recommendations for management of chronic aortic regurgitation (AR) are based on AR severity, symptoms and repercussions on the left ventricle (LV), only providing modest risk stratification value in patients with AR. The objective was to assess the prognostic value of a new staging classification characterizing the extent of cardiovascular damage for risk stratification in patients with chronic AR.
Methods:
According to cardiovascular damages at echocardiography, 619 patients with ≥ moderate AR were classified as follows: Stage 0: no cardiovascular damage; Stage 1: LV damage; Stage 2: ascending aorta, left atrial, or mitral valve damage; Stage 3: pulmonary vasculature or tricuspid valve damage; and Stage 4: right ventricular damage. Study primary endpoint was all-cause mortality and the secondary endpoint was a composite of all-cause mortality and cardiovascular hospitalization.
Results:
Among 619 patients, 85 (13.7%) were in Stage 0, 138 (22.3%) in Stage 1, 278 (44.9%) in Stage 2, 35 (5.7%) in Stage 3, and 83 (13.4%) in Stage 4. After adjustments, cardiovascular damage stage was independently associated with increased risk of all-cause mortality (hazard ratio [HR]; 95% confidence interval [CI] per 1 stage increase, 1.49 [1.27 to 1.75]; P < 0.001) and the composite of events (HR,1.17 [1.03-1.34]; P = 0.02). Stage ≥ 2 was independently associated with increased risk of all-cause mortality (HR, 3.02 [1.83-4.99]; P < 0.001) and the composite of events (HR, 1.88 [1.29-2.73]; P < 0.001). Net reclassification index analyses showed incremental value of the new classification (net reclassification index [NRI] = 0.40; P < 0.001).
Conclusions:
This new cardiovascular damage staging classification provides powerful prognostic value in patients with chronic AR and may be useful to enhance risk stratification and trigger intervention, particularly in asymptomatic AR.
Related Concept Videos
Aortic Regurgitation I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation III: Medical Management
Aortic Regurgitation IV: Nursing Management
Heart Failure IV: Classification and Diagnostic Evaluation
Mitral Regurgitation I: Introduction

